About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 12 results:

Letter

Daclatasvir plasma concentration assessment in HIV–HCV-coinfected real-life patients

Audrey Taton, Philippe Colson, Catherine Dhiver, Jean-Marie Ruiz, Sylvie Bregigeon, Christelle Tomei, Emmanuelle Ressiot, Amélie Menard, Isabelle Poizot-Martin, Isabelle Ravaux, Bruno Lacarelle, Caroline Solas

Antiviral Therapy 2017; 22:731-733


Case report

Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pills

Matthijs van Luin, Gerjanne ter Beest, Lia E Wijnberger, Caroline MA Swanink, David M Burger, Jet H Gisolf

Antiviral Therapy 2017; 22:727-729


Case report

Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation

Wilson Lam, Zeyad Al-Shaibani, Deepali Kumar, Auro Viswabandya, Santhosh Thyagu, Fotios V Michelis, Dennis (Dong-Hwan) Kim, Jeffrey H Lipton, Hans A Messner, Uday Deotare

Antiviral Therapy 2017; 22:721-725


Short communication

The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy

Menglin Shan, Zhen Shen, Hua Sun, Jianghua Zheng, Min Zhang

Antiviral Therapy 2017; 22:717-720


Short communication

Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors

Clément Fage, Véronique Tu, Julie Carbonneau, Yacine Abed, Guy Boivin

Antiviral Therapy 2017; 22:711-716


Original article

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study

John Lubel, Simone Strasser, Katherine A Stuart, Gregory Dore, Alexander Thompson, Stephen Pianko, Steven Bollipo, Joanne L Mitchell, Vincenzo Fragomeli, Tracey Jones, Sarah Chivers, Paul Gow, David Iser, Miriam Levy, Edmund Tse, Alessia Gazzola, Wendy Cheng, Saroj Nazareth, Sam Galhenage, Amanda Wade, Martin Weltman, Alan Wigg, Gerry MacQuillan, Joe Sasadeusz, Jacob George, Amany Zekry, Stuart K Roberts, the Australian Liver Association Clinical Research Network (ALA CRN)

Antiviral Therapy 2017; 22:699-710


Original article

Antiviral activity of nobiletin against chikungunya virus in vitro

Shih-Chao Lin, Mei-Chun Chen, Shiming Li, Chi-Chen Lin, Tony T Wang

Antiviral Therapy 2017; 22:689-697


Original article

Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B

Umaporn Limothai, Natthaya Chuaypen, Apichaya Khlaiphuengsin, Salyavit Chittmittraprap, Yong Poovorawan, Pisit Tangkijvanich

Antiviral Therapy 2017; 22:681-688


Original article

Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation

Allison Ross Eckard, Julia C Rosebush, Mary Ann O’Riordan, Chanda C Graves, Ashley Alexander, Anita K Grover, S Thera Lee, Jakob G Habib, Joshua H Ruff, Ann Chahroudi, Grace A McComsey

Antiviral Therapy 2017; 22:669-680


Original article

CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy

Kathy Petoumenos, Jun Yong Choi, Jennifer Hoy, Sasisopin Kiertiburanakul, Oon Tek Ng, Mark Boyd, Reena Rajasuriar, Matthew Law, the Australian HIV Observational Database, the TREATAsia HIV Observational Database

Antiviral Therapy 2017; 22:659-668


Page:
Copyright © Nucleus Global 2018. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.